CLINICAL_TRIALS
trial_result
· 2017-06-16
Clinical Trial Update: Everolimus in de Novo Kidney Transplant Recipients [Phase 3]
Summary
A Phase 3 trial evaluating everolimus in de novo kidney transplant recipients has completed, with results posted in June 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2017-06-16